- Home
- AGNCM vs KLTOW Comparison
AGNCM vs KLTOW Comparison
Compare AGNCM & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
AGNCM
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
Current Price
Current Price
Company Overview
Basic Information| Metric | AGNCM | KLTOW |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | AGNCM | KLTOW |
|---|---|---|
| Price | $24.59 | $0.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 14.3K | N/A |
| Earning Date | 10-20-2025 | N/A |
| Dividend Yield | ★ 9.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $956,000,000.00 | N/A |
| Revenue This Year | $8.02 | N/A |
| Revenue Next Year | $65.46 | N/A |
| P/E Ratio | $16.58 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.01 | N/A |
| 52 Week High | $25.60 | N/A |
Technical Indicators
Market Signals| Indicator | AGNCM | KLTOW |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 50.65 |
| Support Level | $24.31 | $0.13 |
| Resistance Level | $24.60 | $0.15 |
| Average True Range (ATR) | 0.17 | 0.01 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 80.52 | 50.36 |
Price Performance
Historical ComparisonAbout AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.